Sphygmomanometer

Sphygmomanometer,Aneroid Sphygmomanometer,Palm Sphygmomanometer,Mercury Sphygmomanometer,Stand Sphygmomanometer

« Medical equipment markets favor high-energy low semiconductor productsChina Sphygmomanometer manufacturers »

Hard mainstream semiconductor manufacturers have merit medical market

ST: to combat avian flu provide rapid program

As the world's largest semiconductor company, ST (STMicroelectronics) in promoting high-caliber medical electronic technology to the development of the field has played an important role.

In 2006, ST and diagnostics laboratory cooperation in the use of rapid testing sphygmomanometer contingency chip technology development laboratory test bird flu terminal. Trials using ST's In-Check platform, the development of a laboratory can be confirmed only once a patient is infected with the avian flu (H5N1) or subtype of influenza A or B applications, and now these two diseases require repeated tests and then finally diagnosed. This project builds on the diagnosis developed by the ST chip complete In-Check platform. This platform allows users to a single chip, a small sample accurate and reliable processing and analysis of complex, can significantly reduce the testing time, significantly reducing the complexity of the equipment required. Moreover, such independent films on the laboratory method eliminates the conventional method of cross pollutants inherent dangers.

The World Health Organization recently recognized the rapid diagnosis of human fight against bird flu first demand, ST advanced semiconductor technology combined mutation of the avian flu testing technology, will enable effective and timely testing and treatment become possible, so that the spread of infectious diseases can be controlled in advance.

On April 19, 2007, and ST Debiotech announced that the two sides signed a unique micro-manufacturing sales insulin injection pump strategic cooperation agreement.

This highly miniaturized single insulin injection pump combines Debiotech insulin injection technology and ST's large-scale manufacturing of micro-chip production capacity. Flow-control technology can electronically control the number of very small liquid flows. This marks the injection pump CSII therapy in the development and application of the one step forward, and that the sophisticated technology will also be applied to other biochemical applications.

Using MEMS technology can pump nanometer precision control doctor insulin dose. The accuracy of dose effect is to determine the level of a key factor, but also help reduce long-term drug injection negative role. Nano-liquid injection pump on the control accuracy can be achieved by Nano, a level very close to human insulin injection volume. Moreover, as a large-scale semiconductor manufacturing technologies using a one-time product, this MEMS-based nano-injection pump is also very low cost.

Debiotech by the development, production, and the ST insulin injection pump marks of Microfluidic MEMS technology was first applied to the field of diabetes treatment. ST micro flow control products, other biotechnology project also includes the mainly used to detect sepsis and the avian flu Check In-chip experimental platform.

Comments: The high-tech electronic products in the field of medical research, ST will establish a responsible corporate image of the good society.

- Katherine: power-propelled medical electronic device market

Fairchild has applied to a wide range of medical electronic equipment portfolio, the company's high-voltage IGBT for defibrillator; USB 2.0 transceiver for blood pressure monitor; Μ SerDesTM serializer / deserializer for small displays with cameras and medical applications; Using advanced IntelliMAX load switching the portable medical equipment in the power management and protection; the integrated switch MOSFET, PWM controller to be used in scanners, ultrasonic inspection device, in consultation mirror, film scanners and many other products for medical applications generate huge ESD protection, power and size advantage. Fairchild used for defibrillator for IGBT and in a variety of common power supply design made good progress.

In May 2007, Fairchild introduced new high-frequency integrated boost converter FAN5336, enabling designers to obtain 87% of system efficiency, low EMI and save board space, widely applied to small LCD backlight voltage and white LED lighting design. The 1.5MHz switching frequency boost converter output voltage with a broad range (9V - 33V), and NFET switches integrated in size only 3 x 3 x 0.6 mm thin molded leadless package (UMLP). FAN5336 are smaller than the commonly used SOT-mount devices will be smaller and can provide more features, including a higher peak current (1.5A), higher than similar devices 1.0A; Outstanding ability to import and load regulation (0.2%); The high switching frequency (1 .5 MHz). Therefore, the FAN5336 help phones and smart phones, MP3 players, medical equipment and many other portable applications will be noise, heat generation to a minimum. In addition, the high-frequency converters can use smaller components to help design the best use of board space, while reducing the complexity of the design.

In July 2007, Fairchild introduced the new FPF250X IntelliMAX devices, input voltage of 4.5V - 20V. These highly integrated load switches against the flow of potential damage to provide comprehensive protection, over-current damage to the industrial, telecommunications, medical, notebook computers and consumer applications such as low power design implications. FPF250X devices with thermal shutdown, controlled by Qualcomm and undervoltage lockout protection and control functions, 0.23 ohm current limiting N-channel MOSFET integrated in a space-saving SOT23 package, which simplifies the design, reduce component count and significantly reduced PCB area.

Comment: As one of the power device market vendors, Fairchild's products in the medical market with the application of natural advantages, the market is expected to further enhance the attention.

Xilinx: in the field of medical imaging strengthen influence

Xilinx (Xilinx) recently launched a Spartan-3A low-power DSP (LP) devices, low-cost and low-power applications such as FPGA field of military communications and tactical radio systems, wireless access points and portable medical equipment to provide high-performance digital signal processing (DSP) capability . The device is now in volume production.

Compared with the standard devices, Spartan-3A low-power DSP (LP) devices to reduce the static power consumption by 50%, while in standby mode, static power consumption is reduced up to 70%. Meanwhile, the Spartan-3A low-power DSP devices also feature industrial grade rating. To reduce power consumption and Spartan-Series DSP inherent dedicated DSP for integrated circuits and the dynamic power has advantages complementary with each other. In fact, compared with other similar products FPGAs, Spartan-3A DSP 3400A LP with 25% power efficiency advantage of the lowest-cost device in 250MHz clock speeds of up to 4.06GMACs/mW. The most important point, Spartan-3A DSP quantities can provide to clients.

Xilinx and the field of medical imaging customers already have many years of cooperation. The Spartan-3A launch DSP, Xilinx Virtex-4 SX and Virtex-5 SXT for high-performance DSP applications is optimized. Xilinx in the areas of medical imaging customers around the world, Xilinx products used in a variety of applications, including ultrasound, CT scanners, MRI and other. Xilinx customer choice because of its need for high computing power DSP, high reliability, perfect connectivity, and the optimal cost to transmit large amounts of data.

Comments: With higher resolution and 3D medical imaging equipment as a whole in an irreversible trend, I believe in this market Xilinx's influence will continue to strengthen.

Altera: structured ASIC customers reduce medical risks

If the customers to design high-performance products, such as CT scanning equipment can be used Altera's STRATIX Series products; To design a low-cost products, such as portable products can be used Altera's Cyclone series of products, such as medical ultrasound system, in this two products to choose.

In addition, Altera Corporation on the market only provide structured ASICs, this is a very good strategy, customers using high-performance STRATIX End product design, if not to the future, we can use structured ASIC program, which not only reduces the cost, but also in structured ASIC, other integrated ASIC, customers now have a choice. HARDCOPY and structured ASIC and FPGA devices using the same package, because the health care system to undergo audit, if adopted FPGA design products, after a review, PC board does not need to change the structure of the device can use. Even still vetted, customers will be relatively low risk.

Shenzhen Telecom companies Altera FPGAs developed 3D-CBS technology. The 3D-CBS system, each photon detection board by 20 Altera FPGAs to accelerate digital signal processing functions, which is very critical areas as digital signal processing speed can be accelerated to reduce inspection time and improve image quality, thereby reducing equipment for the radiation patients. Telecom CEO Dario Crosetto said Altera FPGAs help companies develop high-performance products, and shorten time-to-market products.

Comments: has been vigorously advocating the concept of structured ASIC Altera found in the medical electronics field advantage lies.

AMS: ASIC Application program more medical products

Semiconductor products in the medical, AMS (Austria Microelectronics) products used mainly in the following product categories:

Digital X-ray machines: Many well-known companies in the medical use of the AMS precision amplifier components and other specialized X-ray machines to speed up the imaging speed, making the diagnosis more precise, but also significantly reduce the time of exposure to radiation.

CT scanners: A number of well-known medical equipment to use the AMS high-precision sensor interface, making human internal 3D imaging more clear, fast, and greatly reduce the patients X-ray radiation.

Glucose Meter: AMS provides high sensitivity sensor interface and a dedicated controller chips, extending battery life, access to the most accurate data.

Pacemaker monitoring watches: AMS provided by the sensor interface and wireless connectivity coding technology to the chest and watches to establish data connections more secure, ultra-low-power products to extend battery life.

Electric toothbrush: AMS Motor management and provide technical aspects of charging a single-chip low-cost solution that enables high-speed products with more immediate feedback vibration and pressure.

Pacemaker: AMS to provide ultra-low power, the power management chip.

AMS-heart rate monitor for product 5.6kHz receiver ASIC, with the importation of low-noise amplifier (60nV/sqrt-Hz) and six Flash ADC, built-in 32kHz crystal oscillator, the current of 0.5 microamps. Meanwhile, sphygmomanometer in order to provide products of glucose in the blood glucose monitoring accurate ASIC solutions, as front-end integration of sensors and power management, significantly reducing the number of external components, and standby current of 0.8 µ A, 0 ° C temperature range of -40 ° C temperature drift of ± 25 ppm / K . In addition, AMS also introduced ASIC counter dose inhalers, to ultra-low-power design, standby consumption current of 0.33 µ A, working for mA current consumption.

AMS for CT scanners and X-ray detector such medical imaging products provide a high-performance ASIC solutions. AMS will provide Siemens Medical Solutions Group's new computed tomography (CT) platform provides IC testing electronic equipment.

Comments: In the medical field of semiconductors, although FPGA and ASSP product of growing, but ASIC solutions will continue to play an extremely important role.

Maxim: End owners

(Source: Sphygmomanometer News)

Comment:

◎Welcome to comment post and exchange ideas with us

Calendar

Comments

Previous

Copyright Sphygmomanometer. All Rights Reserved. Sitemap